Literature DB >> 1542892

Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients.

G D Graham1, A M Blamire, A M Howseman, D L Rothman, P B Fayad, L M Brass, O A Petroff, R G Shulman, J W Prichard.   

Abstract

BACKGROUND AND
PURPOSE: Proton magnetic resonance spectroscopy can measure in vivo brain lactate and other metabolites noninvasively. We measured the biochemical changes accompanying stroke in 16 human subjects with cortical or deep cerebral infarcts within the first 3 weeks after symptom onset, and performed follow-up studies on six.
METHODS: One-dimensional proton spectroscopic imaging encompassing the infarct region was performed with a 2.1-T whole-body magnet using the stimulated echo pulse sequence and an echo time of 270 msec.
RESULTS: All but one of the cortical stroke patients had increased lactate within or near the infarct. Persistently elevated cerebral lactate was documented in five of six cases studied serially as long as 251 days after infarction. N-acetylaspartate levels were decreased in most cortical strokes. Elevated lactate, accompanied by minimal reduction in N-acetylaspartate, was recorded in two of four patients in the first week following a small subcortical infarct.
CONCLUSIONS: Long-term elevation of lactate commonly occurs after stroke. This lactate may arise from ongoing ischemia or infiltrating leukocytes, or it may be a residual of the lactate formed during the initial insult. The ability to observe stroke-elevated lactate pools at any time after lesion onset provides an approach to distinguishing among these possibilities in the future.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542892     DOI: 10.1161/01.str.23.3.333

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  20 in total

1.  Prognostic significance of metabolic changes detected by proton magnetic resonance spectroscopy in ischaemic stroke.

Authors:  F Federico; I L Simone; C Conte; V Lucivero; P Giannini; M Liguori; E Picciola; C Tortorella
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

2.  Correlation of cerebral metabolites with functional outcome in experimental primate stroke using in vivo 1H-magnetic resonance spectroscopy.

Authors:  A L Coon; F Arias-Mendoza; G P Colby; J Cruz-Lobo; J Mocco; W J Mack; R J Komotar; T R Brown; E S Connolly
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

Review 3.  Functional imaging and related techniques: an introduction for rehabilitation researchers.

Authors:  Bruce Crosson; Anastasia Ford; Keith M McGregor; Marcus Meinzer; Sergey Cheshkov; Xiufeng Li; Delaina Walker-Batson; Richard W Briggs
Journal:  J Rehabil Res Dev       Date:  2010

4.  An experimental proton magnetic resonance spectroscopy analysis on early stage of acute focal cerebral ischemia.

Authors:  Li Yi; Suming Zhang; Xinjiang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

5.  Role of HIF-1α in the hypoxia inducible expression of the thiamine transporter, SLC19A3.

Authors:  Kristy Zera; Rebecca Sweet; Jason Zastre
Journal:  Gene       Date:  2016-10-12       Impact factor: 3.688

6.  Proton magnetic resonance spectroscopy (1H-MRS) for the evaluation of treatment of brain tumours.

Authors:  K Houkin; K Kamada; Y Sawamura; Y Iwasaki; H Abe; T Kashiwaba
Journal:  Neuroradiology       Date:  1995-02       Impact factor: 2.804

Review 7.  Nuclear magnetic resonance imaging and spectroscopy of human brain function.

Authors:  R G Shulman; A M Blamire; D L Rothman; G McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Proton magnetic resonance spectroscopy in patients with ischemic stroke.

Authors:  F Federico; C Conte; I L Simone; P Giannini; M Liguori; E Picciola; C Tortorella; E Ferrari
Journal:  Ital J Neurol Sci       Date:  1994-11

9.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Reversible loss of N-acetylaspartate after 15-min transient middle cerebral artery occlusion in rat: a longitudinal study with in vivo proton magnetic resonance spectroscopy.

Authors:  Junchao Qian; Baojin Qian; Hao Lei
Journal:  Neurochem Res       Date:  2012-10-18       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.